IP Library Patent Application 14100871
Patent Application
App. No. 14/100,871

Topical Dermal Formulations

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
14/100,871
Abstract

An autologous topical formulation containing conditioned medium obtained from culture of autologous fibroblasts has been developed. Unlike other topical formulations, it is autologous since it is derived solely from cells obtained by the person who is to use the formulation. This avoids any possible reaction with proteins derived from the cells. Preferred formulations include gels, creams, lotions, and ointments. The topical formulations of conditioned medium obtained by culturing autologous dermal fibroblasts are topically administered to individuals for the prevention and treatment of scarring, reduction in signs of aging, and improvement in quality of skin.

Claims (22)

1 . A topical cell-free formulation consisting essentially of

An excipient for topical application to the skin, and

Conditioned culture media obtained from the primary harvest of cultured biopsied fibroblasts, the fibroblast cell culture consisting essentially of fibroblasts obtained from an individual screened for disease and compatibility prior to culturing, wherein the excipient is blended with the conditioned culture media or materials therein to form the formulation.

2 . The formulation of claim 1 selected from the group consisting of a gel, ointment, lotion, emulsion, cream, foam, mousse, liquid, spray, suspension, dispersion and aerosol.

3 . The formulation of claim 1 wherein the fibroblasts have been passaged multiple times to produce the conditioned culture media.

4 . The formulation of claim 3 wherein the fibroblasts are passaged after reaching 40% confluence.

5 . The formulation of claim 1 wherein the autologous fibroblasts are obtained from three 3-mm punch skin biopsies.

6 . The formulation of claim 1 wherein the formulation contains the material obtained from 1.5 liters of conditioned cell culture media where the cells are grown to at least 80% cell confluence.

7 . A method of making a topical cell-free formulation comprising combining

An excipient for topical application to the skin, and

Conditioned culture media obtained from the primary harvest of cultured fibroblasts, the fibroblast cell culture consisting essentially of fibroblasts obtained from an individual screened for disease and compatibility prior to culturing.

8 . The method of claim 7 wherein the formulation is selected from the group consisting of a gel, ointment, lotion, emulsion, cream, foam, mousse, liquid, spray, suspension, dispersion and aerosol.

9 . The method of claim 7 wherein the fibroblasts have been passaged multiple times to produce the conditioned culture media.

10 . The method of claim 7 wherein the fibroblasts are passaged after reaching 40% confluence.

11 . The method of claim 7 wherein the autologous fibroblasts are obtained from three 3-mm punch skin biopsies.

12 . The method of claim 7 wherein the formulation contains the material obtained from 1.5 liters of conditioned cell culture media where the cells are grown to at least 80% cell confluence.

13 . The method of claim 7 wherein the conditioned cell culture media is dried to produce material which is blended with the excipient.

14 . A method for treating skin comprising topically administering to the skin a topical cell-free formulation comprising

An excipient for topical application to the skin, and

Conditioned culture media obtained from the primary harvest of cultured fibroblasts, the fibroblast cell culture consisting essentially of fibroblasts obtained from an individual screened for disease and compatibility prior to culturing.

15 . The method of claim 14 wherein the formulation is administered in an effective amount to reduce scarring or signs of aging.

16 . The method of claim 14 wherein the formulation is administered in an effective amount to improve skin quality.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 18, 2021
From: FIBROCELL TECHNOLOGIES, INC.
To: FIBROCELL SCIENCE, INC.
Reel/Frame 055641/0367 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 18, 2021
From: FIBROCELL SCIENCE, INC.
To: CASTLE CREEK BIOSCIENCES, LLC
Reel/Frame 055642/0372 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 31, 2013
From: MASLOWSKI, JOHN M.; DALY, DECLAN
To: FIBROCELL TECHNOLOGIES, INC.
Reel/Frame 031861/0529 →